WHO recommends use of innovative HIV drug

The World Health Organisation (WHO) has recommended the use of the HIV drug dolutegravir(DTG) as the preferred first-line and second-line treatment for all populations. This drug can also be used for patients including pregnant women and those of childbearing potential. Dolutegravir(DTG) which is sold under the brand name Tivicay is an antiretroviral medication used together… Continue reading WHO recommends use of innovative HIV drug